Global Patent Protection for Cutting-Edge Biotechnologies

Niedlfree Technologies  stands at the forefront of biopharmaceutical innovation, with a robust intellectual property portfolio that safeguards our discoveries across the world’s major markets. Our proprietary technologies and processes are protected by granted patents in key strategic regions, including the United States, the European Union, Japan, and Australia. This global protection ensures the exclusivity and integrity of our advanced product pipeline.

We are currently developing a powerful suite of therapeutic molecules, including complex peptides and next-generation biologics such as Insulin, Liraglutide, Semaglutide, and Teriparatide. Furthermore, we are expanding our reach into the future of medicine with pioneering research in Gene Therapy products. Our commitment to strong IP and advanced R&D positions us as a trusted partner in delivering high-quality, accessible biotech solutions.

Product Pipeline & Intellectual Property Status